I Sold My Startup A Year After Founding It. Here's Why That Was The Fastest Way To Build Real-World Healthcare AI
Louis Blankemeier, co-founder and CEO of healthcare AI startup Cognita, explains why he sold his company less than a year after founding it. Cognita built AI models that interpret medical images such as X-rays and CT scans across tens of thousands of potential diagnoses and generate full radiology reports. Faced with a choice between raising venture capital to stay independent or accepting an acquisition by Radiology Partners, the world's largest radiology practice, he argues that joining a large, established company was the fastest path to deploying reliable clinical AI at scale.
Key Takeaways
- Although the conventional wisdom in tech is that real ambition means staying independent, sometimes joining forces through an acquisition by a large, established company is what it takes to improve your mission's odds.
Guest author Louis Blankemeier, co-founder and CEO of Cognita, explains how that process worked for his healthcare startup.
- The conventional wisdom in tech is that real ambition means staying independent.
But in asking ourselves what it would truly take to transform healthcare, the answer was different.
- Despite the persistent narrative that AI will make radiology obsolete, the reality is that the problem is extraordinarily difficult.
A single CT study, for example, can contain 10 high-resolution volumetric series, effectively 3D videos.
- But the real world kept introducing new failure modes.
After more than a decade of significant capital investment, only a handful of companies have approached true reliability.
- It requires vast clinical resources and operational infrastructure to redesign clinical workflows around AI, engineer systems that perform reliably at scale, conduct large-scale research studies, secure regulatory clearance, refine models safely, and continuously monitor performance post-deployment.
Although the conventional wisdom in tech is that real ambition means staying independent, sometimes joining forces through an acquisition by a large, established company is what it takes to improve your mission's odds. Guest author Louis Blankemeier, co-founder and CEO of Cognita, explains how that process worked for his healthcare startup. Guest Author By Louis Blankemeier In October 2024, my co-founders and I set out to make our Ph.D. research useful in the real world.
We had built AI models that could interpret medical images such as X-rays and CT scans across tens of thousands of potential diagnoses, generating comprehensive radiology reports that mirror how radiologists reason in clinical practice. At a time when AI in radiology was limited to flagging a handful of specific conditions, this marked a fundamental shift. Less than a year later, we faced a critical fork in the road: raise venture capital and continue independently, or accept an acquisition offer from Radiology Partners , the world's largest radiology practice.
The conventional wisdom in tech is that real ambition means staying independent. But in asking ourselves what it would truly take to transform healthcare, the answer was different. Clinical AI is highly regulated with long sales cycles and complex stakeholder dynamics, where structural advantages tend to harden market positions and compound over time.
For more details please read the original article at Crunchbase M&A.